On one hand, this secretome could be deleterious, as IL-1β might increase vascular permeability [66], and IL-6 could inhibit dendritic cells (DCs) [67], support tumor cell migration [68], and, just like IL-8, is able to promote tumor growth [69,70]. The gene discussed is IL6; the disease is neoplasm.